HELIUS MEDICAL TECHNOLOGIES (HSDT)
US42328V8019 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to HSDT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.08. This target is 189.36% above the current price.
HSDT was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about HSDT.
In the previous month the buy percentage consensus was at a similar level.
HSDT was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-05 | Roth MKM | Maintains | Buy -> Buy |
| 2022-12-20 | Maxim Group | Initiate | Buy |
| 2022-08-23 | Roth Capital | Initiate | Buy |
| 2021-11-15 | Noble Capital Markets | Downgrade | Outperform -> Market Perform |
| 2021-03-24 | Noble Capital Markets | Initiate | Outperform |